“Cystatin C as an Early Marker of Cardiorenal Syndrome Type 1 in Patients Admitted with Acute Heart Failure”, Nep. Med. Coll. J., vol. 24, no. 4, pp. 316–320, Dec. 2022, doi: 10.3126/nmcj.v24i4.50586.